Key market opportunities in the AI-powered rare disease diagnosis domain include leveraging AI for personalized medicine, ...

Whether we are predisposed to particular diseases may depend to a large extent on variations in our genomes, but the influence on the presentation of certain pathological traits of genetic variants ...

The most advanced artificial intelligence programs are now capable of significantly accelerating pharmaceutical research by modeling molecular interactions. However, a team from the University ...

The AI microscopy market is driven by personalized medicine, precision therapy demand, and real-time image advancements.

Bloomington pilot uses AI and genetic testing to detect familial hypercholesterolemia, a hidden cause of high cholesterol and heart risks in families.

Key opportunities in the AI clinical genomics interpretation market include the rising demand for precision medicine, wider ...